Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Yuan Fang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-3581-4455; OpenAlex author ID A5101805124. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 4

  1. Regulation of AMPK activation by extracellular matrix stiffness in pancreatic cancer. First author DOI 10.1016/j.gendis.2023.05.022↗
  2. Macropinocytic dextran facilitates KRAS-targeted delivery while reducing drug-induced tumor immunity depletion in pancreatic cancer. Co-author DOI 10.7150/thno.65299↗
  3. E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer via Destabilizing F-Actin Capping Protein CAPZA1. Co-author DOI 10.3389/fonc.2021.634167↗
  4. Corrigendum: E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer via Destabilizing F-Actin Capping Protein CAPZA1. Co-author DOI 10.3389/fonc.2021.693855↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhenkun Lou · 1 shared paper, 2024 · strength 0.26
  2. Xin Xu · 1 shared paper, 2024 · strength 0.26
  3. Min Deng · 1 shared paper, 2024 · strength 0.26
  4. Ye‐Xiong Li · 1 shared paper, 2024 · strength 0.26
  5. Yiyi Liang · 2 shared papers, 2021 · strength 0.22
  6. Yu Gan · 2 shared papers, 2021 · strength 0.22
  7. Hong Tu · 2 shared papers, 2021 · strength 0.22
  8. Mengge Li · 2 shared papers, 2021 · strength 0.22
  9. Jin Li · 2 shared papers, 2021 · strength 0.22
  10. Hui Cong · 2 shared papers, 2021 · strength 0.22
  11. Huiqin Liu · 1 shared paper, 2022 · strength 0.17
  12. Weijian Kong · 1 shared paper, 2022 · strength 0.17
  13. Feng Qian · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.